SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-040753
Filing Date
2023-02-16
Accepted
2023-02-16 08:30:35
Documents
14
Period of Report
2023-02-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d424593d8k.htm   iXBRL 8-K 30277
2 EX-1.1 d424593dex11.htm EX-1.1 165614
  Complete submission text file 0001193125-23-040753.txt   382041

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA amgn-20230215.xsd EX-101.SCH 3871
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amgn-20230215_def.xml EX-101.DEF 13251
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE amgn-20230215_lab.xml EX-101.LAB 21839
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amgn-20230215_pre.xml EX-101.PRE 14154
8 EXTRACTED XBRL INSTANCE DOCUMENT d424593d8k_htm.xml XML 5144
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37702 | Film No.: 23637228
SIC: 2836 Biological Products, (No Diagnostic Substances)